Covered recipient · General Payments record
ARTEM MINALYAN
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2019–2024
$10,369.45
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $6,200.00 | 2 |
| Travel and Lodging | $1,757.50 | 5 |
| Food and Beverage | $904.73 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $8,207.50 | 11 |
| ABBVIE INC. | $231.00 | 6 |
| Acerta Pharma LLC | $125.00 | 1 |
| GENZYME CORPORATION | $125.00 | 1 |
| Aurinia Pharma U.S., Inc. | $124.99 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $48.74 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201920222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $124.58 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105041595 | CMS |
| ABBVIE INC. | $34.24 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105041597 | CMS |
| ABBVIE INC. | $9.45 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105041599 | CMS |
| ABBVIE INC. | $14.28 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105041601 | CMS |
| ABBVIE INC. | $34.78 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105041603 | CMS |
| ABBVIE INC. | $13.67 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105041605 | CMS |
| Amgen Inc. | $258.78 | 03/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1111653223 | CMS |
| Amgen Inc. | $667.20 | 03/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1111653225 | CMS |
| Amgen Inc. | $25.00 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111653227 | CMS |
| Amgen Inc. | $50.00 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111653229 | CMS |
| Amgen Inc. | $50.00 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111653231 | CMS |
| Amgen Inc. | $390.84 | 03/09/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1111653235 | CMS |
| Amgen Inc. | $4,200.00 | 03/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1111653237 | CMS |
| Amgen Inc. | $2,000.00 | 07/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1111653233 | CMS |
| Amgen Inc. | $307.50 | 07/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1111653239 | CMS |
| Amgen Inc. | $133.18 | 07/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1111653241 | CMS |
| Amgen Inc. | $125.00 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111653221 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104610832 | CMS |
| Aurinia Pharma U.S., Inc. | $124.99 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150687597 | CMS |
| GENZYME CORPORATION | $125.00 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139843063 | CMS |
| Novartis Pharmaceuticals Corporation | $27.15 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087141722 | CMS |
| Novartis Pharmaceuticals Corporation | $21.59 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087141724 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.